当前位置:首页 - 行情中心 - 康辰药业(603590) - 财务分析

康辰药业

(603590)

  

流通市值:72.58亿  总市值:73.10亿
流通股本:1.58亿   总股本:1.59亿

康辰药业(603590)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.34亿元,每股收益0.81元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益348512.62万元,未分配利润204136.52万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产404855.67万元,负债56343.06万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入692,220,405.14460,869,253.77212,002,399.05825,397,797.2
营业总成本534,795,468.49340,875,691.38152,416,687.23696,236,061.61
其他经营收益
营业利润161,262,569.23121,192,249.9356,852,397.8139,087,805.17
利润总额148,211,291.92109,767,887.2655,550,359.9138,863,747.55
净利润134,302,584.9996,334,639.1948,137,550.3721,530,544.55
每股收益
其他综合收益-48,898,274.85-44,025,848.89-38,283,346.8658,297,183.27
综合收益总额85,404,310.1452,308,790.39,854,203.5179,827,727.82
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,351,700,571.171,377,549,887.351,192,375,175.061,086,540,037.05
非流动资产:
非流动资产合计2,696,856,164.32,494,265,812.382,692,793,179.962,833,148,853.4
资产总计4,048,556,735.473,871,815,699.733,885,168,355.023,919,688,890.45
流动负债:
流动负债合计433,030,825.67333,523,462.39312,765,161.81352,683,215.26
非流动负债:
非流动负债合计130,399,732.97132,480,066.11132,739,009.6140,841,678.43
负债合计563,430,558.64466,003,528.5445,504,171.41493,524,893.69
所有者权益(或股东权益):
归属于母公司股东权益合计3,196,951,992.493,118,771,943.973,154,272,355.953,144,412,325.67
股东权益合计3,485,126,176.833,405,812,171.233,439,664,183.613,426,163,996.76
负债和股东权益合计4,048,556,735.473,871,815,699.733,885,168,355.023,919,688,890.45
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计706,019,570.76407,103,252.66175,703,267.06915,836,361.4
经营活动现金流出小计622,120,320.66418,780,386.38207,215,474.39743,591,182.91
经营活动产生的现金流量净额83,899,250.1-11,677,133.72-31,512,207.33172,245,178.49
投资活动产生的现金流量:
投资活动现金流入小计1,014,041,071.43831,574,895.41171,164,986.291,300,620,310.47
投资活动现金流出小计945,353,149.48587,583,874.14132,522,406.221,499,020,597.18
投资活动产生的现金流量净额68,687,921.95243,991,021.2738,642,580.07-198,400,286.71
筹资活动产生的现金流量:
筹资活动现金流入小计256,505,696.4784,705,761.6239,659,140227,232,614.94
筹资活动现金流出小计291,205,997.07140,690,367.3724,636,813.3235,503,922.34
筹资活动产生的现金流量净额-34,700,300.6-55,984,605.7515,022,326.7-8,271,307.4
汇率变动对现金及现金等价物的影响-1,701.257,729.741,218.83-2,816,383.01
现金及现金等价物净增加额117,885,170.2176,337,011.5422,153,918.27-37,242,798.63
期末现金及现金等价物余额307,862,872.04366,314,713.38212,131,620.11189,977,701.84
补充资料:
现金及现金等价物的净增加额-176,337,011.54--37,242,798.63
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋谭紫媚0.941.161.352025-09-08
国盛证券张玉,张金洋,胡偌碧0.951.151.382025-09-05
首创证券王斌1.061.271.522025-09-02
平安证券叶寅,韩盟盟0.831.111.342025-08-29
中航证券李蔚0.871.111.322025-08-29
TOP↑